Skip to main content

Retailers & Pharmacies Excluded From Zantac MDL

Retailers & Pharmacies Excluded From Zantac MDL

Retailers & Pharmacies Excluded From Zantac MDL

Introduction

A Florida federal judge has ordered to exclude the pharmacies and retailers in Zantac multidistrict litigation by stating that the Zantac manufacturers are to be blamed for carcinogen forming in the drug.

Walgreen Co., The Kroger Co., Albertsons Cos. Inc., CVS Pharmacy Inc., Costco Wholesale Corp., Amazon.com Inc., and a few companies are freed from the Zantac claims as ordered by the U.S. District Judge Robin L. Rosenberg.

The consumers alleged that the retailers, pharmacies, and distributors were negligent while storing Zantac, which resulted in forming of carcinogen in the drug, which is harmful to the users. Whereas the retailers and pharmacies argued that they were not responsible for carcinogens found in Zantac, even Judge Robin L. Rosenberg agreed with the retailers and pharmacies by rejecting the consumers' appeal.

The judge said that the defendants involved in the lawsuits are large companies, and the court requires at least one concrete allegation of the breach to support the claim of a systematic failure of the manufacturers in Zantac litigation.

The judge even said that the court didn't restrict the plaintiffs from investigating if the defendants had deliberately exposed the drug to heat or failed to maintain the required parameters while storing it.

Sanofi SA, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals Inc., and GlaxoSmithKline PLC are some of the major defendants involved in the Zantac MDL, along with generic-drug makers, retailers, distributors, and active pharmaceutical ingredient makers. All of them face similar claims of false advertising, failure to warn, and other claims regarding NDMA in the medication.

In 2019, the U.S. Food and Drug Administration detected traces of NDMA in Zantac and issued a warning to the manufacturers. In 2020, the agency mandated to put a label on the products stating that storing the drug in higher temperatures can result in higher levels of the carcinogen.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!